Company · CIK 1828316

# Pharming Group N.V.

| CIK | [1828316](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001828316) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | P7 |
| Business address | Netherlands |
| Listed | PHAR (Nasdaq) |
| First annual or quarterly report | 2021-04-07 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-250984 | IPO Final prospectus | 2020-11-25 | 2020-12-23 | 5 |

## Filings

 7

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2020-12-23 | [424B4](https://www.sec.gov/Archives/edgar/data/1828316/000119312520325787/0001193125-20-325787-index.htm) Final prospectus | 333-250984 | 0001193125-20-325787 |
| 2020-12-22 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1828316/999999999520003639/9999999995-20-003639-index.htm) Declared effective | 333-251421 | 9999999995-20-003639 |
| 2020-12-22 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1828316/999999999520003627/9999999995-20-003627-index.htm) Declared effective | 333-250984 | 9999999995-20-003627 |
| 2020-12-22 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1828316/000119312520324278/0001193125-20-324278-index.htm) Amendment | 333-250984 | 0001193125-20-324278 |
| 2020-12-17 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1828316/000119312520320211/0001193125-20-320211-index.htm) Amendment | 333-250984 | 0001193125-20-320211 |
| 2020-11-25 | [F-1](https://www.sec.gov/Archives/edgar/data/1828316/000119312520303748/0001193125-20-303748-index.htm) Registration filed | 333-250984 | 0001193125-20-303748 |
| 2020-10-14 | [DRS](https://www.sec.gov/Archives/edgar/data/1828316/000095012320010264/0000950123-20-010264-index.htm) Draft made public | 377-03667 | 0000950123-20-010264 |

[All filings of this company](https://equitycapital.markets/filings?cik=1828316) · [CSV](https://equitycapital.markets/filings.csv?cik=1828316)

---
Source page: https://equitycapital.markets/company/1828316 · Data: U.S. SEC EDGAR · CC BY 4.0